Medical Equipment

Point-of-Care (POC) Coagulation Testing Devices Market Expected to Record Steady Growth and Approach $3.49 Billion by 2030

March 16, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Point-of-Care (POC) Coagulation Testing Devices Market At The End Of The 2026–2030 Forecast Period?

The point-of-care (poc) coagulation testing devices market size has observed substantial growth in recent years. This market is set to increase from $2.32 billion in 2025 to $2.55 billion in 2026, registering a compound annual growth rate (CAGR) of 9.7%. The expansion witnessed in the past can be credited to the escalating incidence of coagulation disorders, heightened application of anticoagulant therapies, the proliferation of decentralized healthcare environments, increasing uptake of point-of-care diagnostics, and enhancements in coagulation testing technologies.

The point-of-care (poc) coagulation testing devices market size is projected to experience substantial growth over the upcoming years. It is predicted to reach $3.49 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 8.2%. This anticipated expansion during the forecast period is primarily driven by factors such as the increasing need for home healthcare diagnostics, a growing emphasis on personalized medicine, the broadening availability of telehealth-supported diagnostics, an expanding elderly population, and ongoing advancements in microfluidic testing platforms. Furthermore, significant developments expected in this period include the wider adoption of portable coagulation monitors, an increasing need for quick diagnostic testing at the point of care, the expanded use of home-based coagulation testing kits, greater wireless data connectivity in poc devices, and a heightened focus on ensuring test accuracy and reliability.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15636&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Point-of-Care (POC) Coagulation Testing Devices Market?

The increasing incidence of blood clotting conditions is anticipated to fuel the expansion of the point-of-care (POC) coagulation testing devices market in the future. These disorders hinder the blood’s normal clotting function. Certain lifestyle elements, such as smoking, heavy alcohol intake, and physical inactivity, can contribute to the development of blood clotting disorders. Such habits may compromise blood vessel integrity, alter clotting factor concentrations, and impede blood circulation, thereby elevating the likelihood of irregular clot development. Point-of-care coagulation testing devices provide medical professionals with a rapid means to evaluate a patient’s clotting profile, facilitating prompt modifications to drug dosages and therapeutic strategies. For example, data from July 2025 by the National Blood Authority, an Australia-based blood management agency, indicated 2,788 individuals were affected by hereditary haemophilia A (HMA) in 2023–2024, an increase from 2,681 patients in 2022–2023. Consequently, the growing prevalence of blood clotting conditions stimulates the expansion of the point-of-care (POC) coagulation testing devices market.

What Segment Types Make Up The Point-of-Care (POC) Coagulation Testing Devices Market?

The point-of-care (poc) coagulation testing devices market covered in this report is segmented –

1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers

2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology

3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods

4) By Application: Coagulation Testing, Other Applications

5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users

Subsegments:

1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors

2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles

3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)

Which Market Trends Are Creating New Opportunities In The Point-of-Care (POC) Coagulation Testing Devices Market?

Leading companies in the point-of-care (POC) coagulation testing devices market are developing immunofluorescence-based quantitative analyzers to enhance the diagnosis and management of coagulation disorders. These analyzers function as diagnostic instruments in laboratory environments, designed to measure and quantify specific proteins or molecules involved in the coagulation process, thereby assisting in the detection and treatment of blood clotting conditions. For example, in January 2023, Cipla Limited, an India-based pharmaceutical company, launched Cippoint. This particular immunofluorescence-based quantitative analyzer employs immunofluorescence technology to deliver rapid and accurate test results within 3 to 15 minutes, which aids in speeding up clinical decision-making. Through its intuitive interface, swift processing time, and broad testing capabilities, Cippoint is instrumental in improving diagnostic efficiency, enabling timely clinical decisions, and enhancing patient care outcomes.

Who Are The Key Players Driving Competition In The Point-of-Care (POC) Coagulation Testing Devices Market?

Major companies operating in the point-of-care (poc) coagulation testing devices market are Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, HemoSonics LLC, Sysmex Corporation, Nihon Kohden Corporation, HORIBA Medical, Helena Laboratories Corporation, Diagnostica Stago, Sekisui Diagnostics, Instrumentation Laboratory, Trinity Biotech plc, CoaguSense Inc., iLine Microsystems, Medirox AB, Hemochron Systems, Axis-Shield Diagnostics

Read the full point-of-care (poc) coagulation testing devices market report here:

https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-devices-global-market-report

Which Regions Are Projected To Dominate The Point-of-Care (POC) Coagulation Testing Devices Market In The Coming Years?

North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2025. The regions covered in the point-of-care (poc) coagulation testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Point-of-Care (POC) Coagulation Testing Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15636&type=smp

Browse Through More Reports Similar to the Global Point-of-Care (POC) Coagulation Testing Devices Market 2026, By The Business Research Company

Point Of Care Poc Coagulation Testing Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-devices-global-market-report

Point Of Care Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report

Coagulation Markers Market Report 2026

https://www.thebusinessresearchcompany.com/report/coagulation-markers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795